Whole genome sequencing to study the phylogenetic structure of serotype a


Journal

Canadian journal of microbiology
ISSN: 1480-3275
Titre abrégé: Can J Microbiol
Pays: Canada
ID NLM: 0372707

Informations de publication

Date de publication:
Feb 2020
Historique:
pubmed: 30 10 2019
medline: 24 4 2020
entrez: 30 10 2019
Statut: ppublish

Résumé

This study examined the phylogenetic structure of serotype a

Identifiants

pubmed: 31661630
doi: 10.1139/cjm-2019-0406
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

99-110

Auteurs

Raymond S W Tsang (RSW)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.

Michelle Shuel (M)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.

Tauqeer Ahmad (T)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.

Kristy Hayden (K)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.

Natalie Knox (N)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada.

Gary Van Domselaar (G)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada.

Linda Hoang (L)

BC Public Health Microbiology and Reference Laboratory, Vancouver, British Columbia, Canada.

Gregory J Tyrrell (GJ)

Provincial Laboratory for Public Health, Edmonton, Alberta, Canada.

Jessica Minion (J)

Roy Romanow Provincial Laboratory, Regina, Saskatchewan, Canada.

Paul Van Caeseele (P)

Cadham Provincial Laboratory, Winnipeg, Manitoba, Canada.

Julianne V Kus (JV)

Public Health Ontario, Toronto, Ontario, Canada.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

Marina Ulanova (M)

Northern Ontario School of Medicine, Thunder Bay, Ontario, Canada.

Brigitte Lefebvre (B)

Laboratoire de santé publique du Québec, Institut national de santé publique du Québec, Sainte-Anne-de-Bellevue, Quebec, Canada.

David Haldane (D)

Nova Scotia Health Authority, Halifax, Nova Scotia, Canada.
Dalhousie University, Halifax, Nova Scotia, Canada.

Richard Garceau (R)

Communicable Disease Control Unit, Department of Health, Government of New Brunswick, Fredericton, New Brunswick, Canada.

Greg German (G)

Department of Health, Government of Prince Edward Island, Charlottetown, Prince Edward Island, Canada.

George Zahariadis (G)

Provincial Public Health Laboratory, Eastern Health Microbiology Services, St. John's, Newfoundland and Labrador, Canada.
Department of Laboratory Medicine, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada.

Brendan Hanley (B)

Department of Health and Social Services, Government of Yukon, Whitehorse, Yukon, Canada.

Kami Kandola (K)

Department of Health and Social Services, Government of Northwest Territories, Yellowknife, Northwest Territories, Canada.

Michael Patterson (M)

Department of Health, Government of Nunavut, Iqaluit, Nunavut, Canada.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH